Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Nov 10, 2026 · Filed Nov 12, 2026
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Insider buying
Traded Nov 12 · filed 1 day later
Perspective Therapeutics's Chief Medical Officer paid $30K out of pocket for Perspective Therapeutics shares. 1 other person at Perspective Therapeutics bought some too, in the same month. Shares held went up 24% with this purchase.
Insider buying
First insider buy since Mar 2025Traded Nov 11 · filed 2 days later
Perspective Therapeutics's Chief Medical Officer paid $5K out of pocket for Perspective Therapeutics shares. 1 other person at Perspective Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
First insider buy since Mar 2025Traded Nov 11 · filed 1 day later
The CEO of Perspective Therapeutics paid $38K out of pocket for Perspective Therapeutics shares. 1 other person at Perspective Therapeutics bought some too, in the same month. It was the first purchase in 20 months.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
